W. Bryan Hubbard

You know, we began this conversation about the realities of the opioid epidemic in America.

While death is the most terminal outcome is measured down about 700,000 Americans, there is a much broader web of hardcore travesty that exists around each of those death outcomes.

And Lonnie experienced that.

She had multiple concussions from her own father.

Like many individuals who experience trauma of this nature, she developed her own drug addiction.

She was in and out of jail.

She was homeless at a different point in time.

She managed to get recovered.

She had a separate traumatic brain injury that was fairly severe in 2018.

And then she was diagnosed with what I believe is called young-onset Parkinson's, Parkinson's diagnosis that is pre-age 50.

Her Parkinson's had progressed to the point to where she could not write because of the tremulousness in her hands.

So when I saw her two weeks ago and she introduced herself, she had all of the appearance and affect of a perfectly healthy human being.

It was only after we sat down and she explained what her experience had been and where she was at now that the Ibogaine disclosure was made.

Her hand was just as calm as mine.

And she said that it had been essentially three months and that she had been able to resume a normal life and that her mind felt restored.

Now, based on the responses we got after our first interview with you, I want to be very careful here.

This is truly the edge of science.

And there is much unknown about the variety of Parkinson's that this can treat.

There's some suggestion that it is better for those who have a genetic predisposition for the disease than it is for those who contract Parkinson's as the result of environmental exposure.

Ibogaine does not appear to have any impact